<DOC>
	<DOCNO>NCT02613091</DOCNO>
	<brief_summary>In a1972 study French Annals Pharmaceuticals , Laroche Laroche report drug clemastine negative effect patient ' color discrimination , ability distinguish different hue arrange correct order . In upcoming clinical trial study effect clemastine vision outcome , lab aim ass color visual performance add assessment color defectiveness clinical endpoint . Color defectiveness ability see certain color , commonly refer color-blindness . Color discrimination defectiveness relate , always correlate . This study aim detect effect , , clemastine color defectiveness healthy control , could confound use outcome endpoint future clinical trial relate clemastine .</brief_summary>
	<brief_title>Effect Clemastine Fumarate Color Vision Healthy Controls</brief_title>
	<detailed_description>Additional evaluation pharmacokinetic data perform confirm pharmacokinetic measure correlate blood level drug color performance see .</detailed_description>
	<mesh_term>Clemastine</mesh_term>
	<criteria>Healthy control Preexisting ophthalmologic condition optic neuritis , macular star , glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>volunteer</keyword>
</DOC>